There were 230 enrolled as of the last call on 10/
Post# of 148264
(Total Views: 631)
Posted On: 10/31/2020 4:04:42 PM
Re: LaundryMoney #63859
There were 230 enrolled as of the last call on 10/20. Assuming Dr.NP provided that information yesterday, that's 5 new enrolls in 10 days.
At this rate, we're looking at 116 days just to get to 293 interim -- which is February 24. And then we have to wait 42 days -- which is April 4. With a potential interim readout 3 weeks later -- it would be May 9.
And that's just the 293 interim -- not the entire trial.
As Dr.NP clearly indicated,
If this rate continues, and/or if we have to fully enroll the trial to 390 (with the inherent delay that will be created by the interim 293), we could very well be looking at Q4-2021.
It is shortsighted mistake to not partner with a BP to get this done quicker.
At this rate, we're looking at 116 days just to get to 293 interim -- which is February 24. And then we have to wait 42 days -- which is April 4. With a potential interim readout 3 weeks later -- it would be May 9.
And that's just the 293 interim -- not the entire trial.
As Dr.NP clearly indicated,
Quote:
“Our guess is, it means that our study is not only proving to be safe, but that it is also effective. If it wasn’t, the DSMC would have stopped our trial due to safety or had us change something to increase our effectiveness. But instead, they have simply recommended we continue our study and recruit the remaining 155 patients we need to complete our study to achieve our primary endpoint.”
If this rate continues, and/or if we have to fully enroll the trial to 390 (with the inherent delay that will be created by the interim 293), we could very well be looking at Q4-2021.
It is shortsighted mistake to not partner with a BP to get this done quicker.
(2)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼